Cargando…
The efficacy of Antipyretic Analgesics administration intravenously for Preventing Rocuronium-Associated Pain/Withdrawal Response: a systematic review and meta-analysis
BACKGROUND: Rocuronium-associated injection pain/withdrawal response (RAIPWR) was non-ideal but occurred frequently when injection intravenously during anesthesia induction. Many studies had reported that pretreating with antipyretic analgesics (AAs) could reduce the occurrence of RAIPWR, but there...
Autores principales: | Wang, Jia, Cui, Yu, Liu, Bin, Chen, Jianfeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7171835/ https://www.ncbi.nlm.nih.gov/pubmed/32312228 http://dx.doi.org/10.1186/s12871-020-00990-3 |
Ejemplares similares
-
Remifentanil Prevents Withdrawal Movements Caused by Intravenous Injection of Rocuronium
por: Choi, Byung In, et al.
Publicado: (2008) -
Time interval between alfentanil and rocuronium administration necessary to prevent rocuronium-induced withdrawal movement
por: Wang, Xiao-Dan, et al.
Publicado: (2022) -
Effect of pretreatment with gabapentin on withdrawal movement associated with intravenous rocuronium injection
por: Yoon, Jin Sun, et al.
Publicado: (2011) -
Fentanyl or ketamine pre-treatment to prevent withdrawal response to rocuronium
por: Kosare, Suchita S, et al.
Publicado: (2017) -
The efficacy of sevolflurane inhalation alone or its combination with intravenous remifentanil against withdrawal movements on rocuronium injection in children
por: Na, Yun Chan, et al.
Publicado: (2014)